If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...
However, fans were most intrigued by newcomer Roger Noble (Conor O’Donnell) and his interest in Nurse Corrigan. While anticipating another lonely Christmas, Nancy was surprised by Roger ...
Call the Midwife fans are convinced newcomer Roger Noble (played by Conor O'Donnell) is set to bring a whole lot of drama as his romance with Nurse Nancy Corrigan (Megan Cusack) was confirmed.
The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks ...
Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...
Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion. Under the terms of the deal, the company will gain the exclusive global ...
Merck (NYSE:MRK) and Chinese biopharmaceutical company Hansoh Pharma (OTCPK:HNSPF) announced a global licensing deal on Wednesday to develop HS-10535, an oral GLP-1 receptor agonist targeted at ...
Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...
RAHWAY, N.J., December 18, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced ...
With Rik Van Looy, who passed away just days before his 91st birthday, gone is a true icon of world and Belgian cycling in particular, as other legends of the sport, Eddy Merckx and Roger De Vlaeminck ...
Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...